Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5RE93 | IM / RA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945655 | IM / LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | X1C89IM | SC / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y003499 | SC / RA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | LC5483 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CX4HL | IM / LA |
Two weeks after vaccinations client developed tingling and numbness to the lower and upper extremities, numbness of tongue and right face paralysis, slurred speech and unable to swallow.
N/A
N/A
None taken
No known allergies
EKG, Lab test, CT Scan of Head, Lumbar puncture.